These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32528832)

  • 1. Characterization of organic anion transporting polypeptide 1b2 knockout rats generated by CRISPR/Cas9: a novel model for drug transport and hyperbilirubinemia disease.
    Ma X; Shang X; Qin X; Lu J; Liu M; Wang X
    Acta Pharm Sin B; 2020 May; 10(5):850-860. PubMed ID: 32528832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics.
    Lu J; Liu J; Guo Y; Zhang Y; Xu Y; Wang X
    Acta Pharm Sin B; 2021 Oct; 11(10):2973-2982. PubMed ID: 34745851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin.
    Zaher H; Meyer zu Schwabedissen HE; Tirona RG; Cox ML; Obert LA; Agrawal N; Palandra J; Stock JL; Kim RB; Ware JA
    Mol Pharmacol; 2008 Aug; 74(2):320-9. PubMed ID: 18413659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR.
    Lu H; Choudhuri S; Ogura K; Csanaky IL; Lei X; Cheng X; Song PZ; Klaassen CD
    Toxicol Sci; 2008 May; 103(1):35-45. PubMed ID: 18296417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
    Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
    J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of a humanized
    Zhang Y; Huang J; Huang S; Liu J; Deng L; Liang C; Guo Y; Yao B; Wang X
    Acta Pharm Sin B; 2024 Apr; 14(4):1592-1604. PubMed ID: 38572097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia.
    Chang JH; Plise E; Cheong J; Ho Q; Lin M
    Mol Pharm; 2013 Aug; 10(8):3067-75. PubMed ID: 23750830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity.
    Evers R; Chu XY
    Mol Pharmacol; 2008 Aug; 74(2):309-11. PubMed ID: 18492796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking organic anion transporting polypeptide 1B1 and 1B3 (OATP1B1 and OATP1B3) interaction profiles to hepatotoxicity - The hyperbilirubinemia use case.
    Kotsampasakou E; Escher SE; Ecker GF
    Eur J Pharm Sci; 2017 Mar; 100():9-16. PubMed ID: 28063966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response.
    Zhang W; Chen L; Feng H; Wang W; Cai Y; Qi F; Tao X; Liu J; Shen Y; Ren X; Chen X; Xu J; Shen Y
    Free Radic Biol Med; 2017 Nov; 112():24-35. PubMed ID: 28688954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of OATP1B1 and 1B3 transporter function using transgenic rodent models and commonly known single nucleotide polymorphisms.
    Choudhuri S; Klaassen CD
    Toxicol Appl Pharmacol; 2020 Jul; 399():115039. PubMed ID: 32407928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.
    Csanaky IL; Lu H; Zhang Y; Ogura K; Choudhuri S; Klaassen CD
    Hepatology; 2011 Jan; 53(1):272-81. PubMed ID: 20949553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.
    Visentin M; Stieger B; Merz M; Kullak-Ublick GA
    J Pharmacol Exp Ther; 2015 Nov; 355(2):145-51. PubMed ID: 26330539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic anion transport polypeptide 1b2 selectively affects the pharmacokinetic interaction between paclitaxel and sorafenib in rats.
    Ma X; Qin X; Shang X; Liu M; Wang X
    Biochem Pharmacol; 2019 Nov; 169():113612. PubMed ID: 31437461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, expression, and functional characterization of full-length and splice variants of murine organic anion transporting polypeptide 1b2.
    Meyer Zu Schwabedissen HE; Ware JA; Tirona RG; Kim RB
    Mol Pharm; 2009; 6(6):1790-7. PubMed ID: 19400585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
    Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
    J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1/1B3.
    Dong J; Olaleye OE; Jiang R; Li J; Lu C; Du F; Xu F; Yang J; Wang F; Jia W; Li C
    Br J Pharmacol; 2018 Sep; 175(17):3486-3503. PubMed ID: 29908072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.
    van de Steeg E; Stránecký V; Hartmannová H; Nosková L; Hřebíček M; Wagenaar E; van Esch A; de Waart DR; Oude Elferink RP; Kenworthy KE; Sticová E; al-Edreesi M; Knisely AS; Kmoch S; Jirsa M; Schinkel AH
    J Clin Invest; 2012 Feb; 122(2):519-28. PubMed ID: 22232210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights in bilirubin metabolism and their clinical implications.
    Sticova E; Jirsa M
    World J Gastroenterol; 2013 Oct; 19(38):6398-407. PubMed ID: 24151358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.